⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29362763 | 1.00 | — | — | |
| SCHEMBL30155277 | 0.98 | CHEK1 (0.41) | — | |
| Bromide SCHEMBL10378261 | 0.98 | CHEK1 (0.41) | — | |
| Piperazine SCHEMBL798343 | 0.88 | HTR2C (0.44) | — | |
| SCHEMBL27748296 | 0.85 | EGFR (0.40) | — | |
| Acetamide SCHEMBL9933180 | 0.85 | NPC1 (0.38) | — | |
| SCHEMBL29991493 | 0.80 | — | — | |
| SCHEMBL35212535 | 0.77 | — | — | |
| SCHEMBL29952007 | 0.70 | PIK3CG (0.39) | — | |
| SCHEMBL27462264 | 0.70 | EGFR (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1792 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325555-A1 | Method of Treating Obesity with a Luteinizing Hormone Receptor Agonist | ICAHN SCHOOL MED MOUNT SINAI (US) | 2025-10-23 | — | — | US | claimed |
| EP-4536352-A2 | METHOD OF TREATING OBESITY WITH A LUTEINIZING HORMONE RECEPTOR AGONIST | Icahn School of Medicine at Mount Sinai (US) | 2025-04-16 | — | — | EP | claimed |
| WO-2024245444-A1 | OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-12-05 | — | — | WO | claimed |
| US-20240208968-A1 | ALPHA V BETA 6 AND ALPHA V BETA 1 INTEGRIN INHIBITORS AND USES THEREOF | DICE MOLECULES SV, INC. | 2024-06-27 | — | — | US | claimed |
| EP-4304716-A1 | ALPHA V BETA 6 AND ALPHA V BETA 1 INTEGRIN INHIBITORS AND USES THEREOF | Dice Molecules Sv, Inc. (US) | 2024-01-17 | — | — | EP | claimed |
| WO-2023239854-A2 | METHOD OF TREATING OBESITY WITH A LUTEINIZING HORMONE RECEPTOR AGONIST | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2023-12-14 | — | — | WO | claimed |
| EP-4263539-A1 | 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE TREATMENT OF INFECTIOUS DISEASES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM (FR) | 2023-10-25 | — | — | EP | claimed |
| US-11679111-B2 | Fatty acid synthase inhibitors | DUKE UNIVERSITY (US) | 2023-06-20 | — | — | US | claimed |
| WO-2022192545-A1 | ALPHA V BETA 6 AND ALPHA V BETA 1 INTEGRIN INHIBITORS AND USES THEREOF | DICE MOLECULES SV, INC. (US) | 2022-09-15 | — | — | WO | claimed |
| WO-2022129376-A1 | 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE|TREATMENT OF INFECTIOUS DISEASES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2022-06-23 | — | — | WO | claimed |
| WO-1997007119-A1 | THIENOPYRIMIDINE DERIVATIVES, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-02-27 | — | — | WO | claimed |
| WO-1996035678-A1 | ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE | PHARMACIA & UPJOHN COMPANY (US) | 1996-11-14 | — | — | WO | claimed |
| EP-0447891-B1 | Thieno(2,3-d)pyrimidine derivatives | BASF AG (DE) | 1994-04-27 | — | — | EP | claimed |
| CN-1076697-A | BIHETEROCYCLIC FUNGICIDAL COMPOUNDS | SCHERING AGROCHEMICALS LTD (GB) | 1993-09-29 | — | — | CN | claimed |
| WO-1993013664-A2 | BIHETEROCYCLIC FUNGICIDAL COMPOUNDS | SCHERING AGROCHEMICALS LIMITED (GB) | 1993-07-22 | — | — | WO | claimed |
| EP-0452002-A2 | Thienopyrimidine derivatives | DOWELANCO (US) | 1991-10-16 | — | — | EP | claimed |
| EP-0447891-A1 | Thieno(2,3-d)pyrimidine derivatives | BASF Aktiengesellschaft (DE) | 1991-09-25 | — | — | EP | claimed |
| EP-0150469-B1 | THIENO(2,3-D)PYRIMIDINE DERIVATIVES AND SALTS THEREOF | MITSUBISHI KASEI CORPORATION (JP) | 1988-06-15 | — | — | EP | claimed |
| US-4695568-A | Thieno[2,3-d]pyrimidine derivatives and salts thereof | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1987-09-22 | — | — | US | claimed |
| EP-0150469-A1 | Thieno(2,3-d)pyrimidine derivatives and salts thereof | MITSUBISHI KASEI CORPORATION (JP) | 1985-08-07 | — | — | EP | claimed |